[Translation] A randomized, open-label, two-dose, single-dose, single-cycle, parallel bioequivalence trial of leflunomide tablets in Chinese healthy subjects under fasting/postprandial oral administration
预试验主要目的:健康受试者餐后状态下,口服单剂量受试制剂与参比制剂后,考察餐后条件下受试制剂与参比制剂在健康受试者体内的药代动力学参数和个体内变异系数,验证血浆中药物浓度分析方法、采血时间、清洗期及消胆胺服药时间等设置的合理性。
正式试验主要目的:健康受试者空腹/餐后状态下,口服单剂量受试制剂与参比制剂后,考察空腹和餐后条件下受试制剂与参比制剂的吸收速度和吸收程度,评价受试制剂与参比制剂是否具有生物等效性。
次要研究目的:观察受试制剂和参比制剂在健康受试者中的安全性。
[Translation] The main purpose of the pre-test is to investigate the pharmacokinetic parameters of the test preparation and the reference preparation in healthy subjects under postprandial conditions after oral administration of a single dose of the test preparation and the reference preparation. and the intra-individual coefficient of variation to verify the rationality of the analysis method of drug concentration in plasma, blood collection time, cleaning period and cholestyramine administration time.
The main purpose of the formal test: healthy subjects take a single dose of the test preparation and the reference preparation under fasting/postprandial conditions, to investigate the absorption rate and absorption degree of the test preparation and the reference preparation under fasting and postprandial conditions, and to evaluate the Whether the test preparation is bioequivalent to the reference preparation.
Secondary research objectives: To observe the safety of test and reference products in healthy subjects.